Receptor specific transepithelial transport of immunogens
CA 2210656 C · Owner: Lencer, Wayne I. · Inventors: Simister, Neil E.; Blumberg, Richard S.; Lencer, Wayne I.
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Methods and products for modulating am immune response are provided. Pharmaceutical preparations contain a conjugate of an antigen and an FcRn binding partner. The conjugates are administered to mammals in effective amounts to modulate the immune system by stimulating the immune response against the antigen or tolerizing the immune system to the antigen. The antigen may be characteristic of a pathogen, of an autoimmune disease of an allergen or of a tumor.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed January 17, 1996 and granted July 5, 2011. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended January 17, 2016.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by January 17, 2018.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.